GLM-20304-72454 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Dose 1 — Pfizer-BioNTech
2021-03-24
Registered in v-safe
2021-03-24
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Stinging eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-13
Dose 2 — Pfizer-BioNTech
2021-07-15
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-13
Survey response — 6 months, dose 2
MedDRA: Rash — Feeling: Good

Free text: Rash

MedDRA releases: 2024-11 · check-in free text available
2021-12-11
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-06-13
Survey response — 6 months, dose 3
MedDRA: Costochondritis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Costochondritia

MedDRA releases: 2024-11 · check-in free text available
2022-12-11
Survey response — 12 months, dose 3
MedDRA: Hyperemesis gravidarum, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Pregnancy with Hyperemesis Gravidarum

MedDRA releases: 2024-11 · check-in free text available
2022-12-11
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-12-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Pfizer-BioNTech
2	2021-04-13	Pfizer-BioNTech
3	2021-12-11	Pfizer-BioNTech	Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-24

Systemic reaction (other): Stinging eyes

Release 10 — 6 months, dose 2

2021-10-13

Symptoms: Rash

Release 12 — 6 months, dose 3

2022-06-13

Symptoms: Costochondritia

Release 12 — 12 months, dose 3

2022-12-11

Symptoms: Pregnancy with Hyperemesis Gravidarum

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Costochondritis	·	·	✓
SD	Hyperemesis gravidarum	·	·	✓
SD	Pregnancy	·	·	✓
SD	Rash	·	·	✓
SRO	Eye pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release